Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia (CROSBI ID 269278)

Prilog u časopisu | stručni rad | međunarodna recenzija

Vučićević Boras, Vanja ; Jurlina, Martin ; Brailo, Vlaho ; Đurić Vuković, Katarina ; Rončević, Pavle ; Bašić Kinda, Sandra ; Gabrić, Dragana ; Vidović Juras, Danica Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia // Acta stomatologica Croatica, 53 (2019), 3; 274-277. doi: 10.15644/asc53/3/9

Podaci o odgovornosti

Vučićević Boras, Vanja ; Jurlina, Martin ; Brailo, Vlaho ; Đurić Vuković, Katarina ; Rončević, Pavle ; Bašić Kinda, Sandra ; Gabrić, Dragana ; Vidović Juras, Danica

hrvatski

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia

A 54-year-old male patient with acute lymphoblastic leukemia was referred to the Department of Oral Medicine.He had a primary refractory disease and was treated according to HOVON71 and HAM pro-tocol. Sixteen days after the start of the HAM protocol the patient developed palatal dark red/brown-ish lesion and maxillary vestibular exophytic lesion. Biopsy specimens from oral lesions were taken and microbiologic evaluation confirmed the presence of Aspergillus fumigatusand Rhizopus genus. The treatment of the patient consisted of the inferior maxillectomy and intravenous posaconazole and amphotericine B for the following 28 days. Since the coinfection with Aspergillusand Rhizopusis extremely rarely seen in the oral cavity, a diagnostic and therapeutic dilemma easily presents itself.

Mouth Diseases ; Mucormycosis ; As-pergillosis ; Immunocompromised Host ; Leukemia

nije evidentirano

engleski

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia

A 54-year-old male patient with acute lymphoblastic leukemia was referred to the Department of Oral Medicine.He had a primary refractory disease and was treated according to HOVON71 and HAM pro-tocol. Sixteen days after the start of the HAM protocol the patient developed palatal dark red/brown-ish lesion and maxillary vestibular exophytic lesion. Biopsy specimens from oral lesions were taken and microbiologic evaluation confirmed the presence of Aspergillus fumigatusand Rhizopus genus. The treatment of the patient consisted of the inferior maxillectomy and intravenous posaconazole and amphotericine B for the following 28 days. Since the coinfection with Aspergillusand Rhizopusis extremely rarely seen in the oral cavity, a diagnostic and therapeutic dilemma easily presents itself.

Mouth Diseases ; Mucormycosis ; As-pergillosis ; Immunocompromised Host ; Leukemia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

53 (3)

2019.

274-277

objavljeno

0001-7019

1846-0410

10.15644/asc53/3/9

Povezanost rada

Dentalna medicina

Poveznice
Indeksiranost